Neurogene Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Neurogene Inc. (NGNE) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 51.83 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-03-25
- Neurogene Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 54.61M shares, a 56.79% increase year-over-year.
- Neurogene Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 54.12M shares, a 106.68% increase year-over-year.
- Neurogene Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 49.39M shares, a 109.85% increase year-over-year.
- Neurogene Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 49.17M shares, a 108.90% increase year-over-year.
- Neurogene Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 51.83M shares, a 91.73% increase from fiscal 2019.
- Neurogene Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 27.03M shares, a 14.93% increase from fiscal 2018.
- Neurogene Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 23.52M shares, a 0.30% increase from fiscal 2017.
- Neurogene Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 23.45M shares, a 24.12% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 123 month |
|---|---|---|---|---|---|---|
| 2020-12-31 | 54.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 54.37M shares derived: average of 2 quarters · filed 2021-03-25 | 52.71M shares derived: average of 3 quarters · filed 2021-03-25 | 51.83M shares 10-K · filed 2021-03-25 | ||
| 2020-09-30 | 54.12M shares 10-Q · filed 2020-11-09 | 51.76M shares derived: average of 2 quarters · filed 2020-11-09 | 50.90M shares 10-Q · filed 2020-11-09 | 46.88M shares derived: average of 4 quarters · filed 2021-03-25 | ||
| 2020-06-30 | 49.39M shares 10-Q · filed 2020-08-12 | 49.28M shares 10-Q · filed 2020-08-12 | 44.46M shares derived: average of 3 quarters · filed 2021-03-25 | 39.89M shares derived: average of 4 quarters · filed 2021-03-25 | ||
| 2020-03-31 | 49.17M shares 10-Q · filed 2020-05-06 | 42.00M shares derived: average of 2 quarters · filed 2021-03-25 | 36.73M shares derived: average of 3 quarters · filed 2021-03-25 | 33.43M shares derived: average of 4 quarters · filed 2021-03-25 | ||
| 2019-12-31 | 34.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 30.51M shares derived: average of 2 quarters · filed 2021-03-25 | 28.18M shares derived: average of 3 quarters · filed 2021-03-25 | 27.03M shares 10-K · filed 2021-03-25 | ||
| 2019-09-30 | 26.19M shares 10-Q · filed 2020-11-09 | 24.86M shares derived: average of 2 quarters · filed 2020-11-09 | 24.43M shares 10-Q · filed 2020-11-09 | 24.20M shares derived: average of 4 quarters · filed 2020-11-09 | ||
| 2019-06-30 | 23.54M shares 10-Q · filed 2020-08-12 | 23.54M shares 10-Q · filed 2020-08-12 | 23.54M shares derived: average of 3 quarters · filed 2020-08-12 | 23.54M shares derived: average of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | 23.54M shares 10-Q · filed 2020-05-06 | 23.54M shares derived: average of 2 quarters · filed 2020-05-06 | 23.54M shares derived: average of 3 quarters · filed 2020-05-06 | |||
| 2018-12-31 | 23.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 23.54M shares derived: average of 2 quarters · filed 2020-03-12 | 23.52M shares 10-K · filed 2020-03-12 | |||
| 2018-09-30 | 23.54M shares 10-Q · filed 2019-11-13 | 23.51M shares 10-Q · filed 2019-11-13 | ||||
| 2018-03-31 | 23.48M shares 10-Q · filed 2019-05-07 | 23.48B shares 10-Q · filed 2018-05-08 | 23.47M shares derived: average of 2 quarters · filed 2020-03-12 | 23.47M shares derived: average of 3 quarters · filed 2020-03-12 | 23.46M shares derived: average of 4 quarters · filed 2020-03-12 | |
| 2017-12-31 | 23.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 23.47M shares derived: average of 2 quarters · filed 2020-03-12 | 23.46M shares derived: average of 3 quarters · filed 2020-03-12 | 23.45M shares 10-K · filed 2020-03-12 | ||
| 2017-09-30 | 23.46M shares 10-Q · filed 2018-11-07 | 23.45M shares derived: average of 2 quarters · filed 2018-11-07 | 23.44M shares 10-Q · filed 2018-11-07 | 5.87B shares derived: average of 4 quarters · filed 2019-03-07 | ||
| 2017-06-30 | 23.44M shares 10-Q · filed 2017-08-08 | 23.43M shares 10-Q · filed 2017-08-08 | 7.82B shares derived: average of 3 quarters · filed 2019-03-07 | 5.87B shares derived: average of 4 quarters · filed 2019-03-07 | ||
| 2017-03-31 | 23.42B shares 10-Q · filed 2018-05-08 | 23.42M shares 10-Q · filed 2017-05-09 | 11.72B shares derived: average of 2 quarters · filed 2019-03-07 | 7.82B shares derived: average of 3 quarters · filed 2019-03-07 | 5.87B shares derived: average of 4 quarters · filed 2019-03-07 | |
| 2016-12-31 | 23.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 20.57M shares derived: average of 2 quarters · filed 2019-03-07 | 19.45M shares derived: average of 3 quarters · filed 2019-03-07 | 18.89M shares 10-K · filed 2019-03-07 | ||
| 2016-09-30 | 17.69M shares 10-Q · filed 2017-11-08 | 17.45M shares derived: average of 2 quarters · filed 2017-11-08 | 17.37M shares 10-Q · filed 2017-11-08 | 17.34M shares derived: average of 4 quarters · filed 2018-03-12 | ||
| 2016-06-30 | 17.21M shares 10-Q · filed 2017-08-08 | 17.21M shares 10-Q · filed 2017-08-08 | 17.23M shares derived: average of 3 quarters · filed 2018-03-12 | 15.88M shares derived: average of 4 quarters · filed 2018-03-12 | ||
| 2016-03-31 | 17.21M shares 10-Q · filed 2017-05-09 | 17.24M shares derived: average of 2 quarters · filed 2018-03-12 | 15.44M shares derived: average of 3 quarters · filed 2018-03-12 | 14.26M shares derived: average of 4 quarters · filed 2018-03-12 | ||
| 2015-12-31 | 17.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 14.55M shares derived: average of 2 quarters · filed 2018-03-12 | 13.28M shares derived: average of 3 quarters · filed 2018-03-12 | 12.64M shares 10-K · filed 2018-03-12 | ||
| 2015-09-30 | 11.84M shares 10-Q · filed 2016-11-09 | 11.28M shares derived: average of 2 quarters · filed 2016-11-09 | 11.10M shares 10-Q · filed 2016-11-09 | 11.00M shares derived: average of 4 quarters · filed 2017-03-09 | ||
| 2015-06-30 | 10.72M shares 10-Q · filed 2016-08-04 | 10.72M shares 10-Q · filed 2016-08-04 | 10.72M shares derived: average of 3 quarters · filed 2017-03-09 | 10.71M shares derived: average of 4 quarters · filed 2017-03-09 | ||
| 2015-03-31 | 10.71M shares 10-Q · filed 2016-05-10 | 10.71M shares derived: average of 2 quarters · filed 2017-03-09 | 10.71M shares derived: average of 3 quarters · filed 2017-03-09 | 10.70M shares derived: average of 4 quarters · filed 2017-03-09 | ||
| 2014-12-31 | 10.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | 10.71M shares derived: average of 2 quarters · filed 2017-03-09 | 10.70M shares derived: average of 3 quarters · filed 2017-03-09 | 8.67M shares 10-K · filed 2017-03-09 | ||
| 2014-09-30 | 10.70M shares 10-Q · filed 2015-11-10 | 10.69M shares derived: average of 2 quarters · filed 2015-11-10 | 7.98M shares 10-Q · filed 2015-11-10 | 6.21M shares derived: average of 4 quarters · filed 2016-03-14 | ||
| 2014-06-30 | 10.68M shares 10-Q · filed 2015-08-06 | 6.61M shares 10-Q · filed 2015-08-06 | 4.71M shares derived: average of 3 quarters · filed 2016-03-14 | 3.61M shares derived: average of 4 quarters · filed 2016-03-14 | ||
| 2014-03-31 | 3.15M shares 10-Q · filed 2015-05-12 | 1.73M shares derived: average of 2 quarters · filed 2016-03-14 | 1.25M shares derived: average of 3 quarters · filed 2016-03-14 | 1.01M shares derived: average of 4 quarters · filed 2016-03-14 | 398.57K shares 10-Q · filed 2014-05-13 | |
| 2013-12-31 | 301.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 301.75K shares derived: average of 2 quarters · filed 2016-03-14 | 301.75K shares derived: average of 3 quarters · filed 2016-03-14 | 301.75K shares 10-K · filed 2016-03-14 | ||
| 2013-09-30 | 301.75K shares 10-Q · filed 2014-11-04 | 301.75K shares derived: average of 2 quarters · filed 2014-11-04 | 301.75K shares 10-Q · filed 2014-11-04 | |||
| 2013-06-30 | 301.75K shares 10-Q · filed 2014-08-11 | 301.75K shares 10-Q · filed 2014-08-11 | ||||
| 2013-03-31 | 301.75K shares 10-Q · filed 2014-05-13 | |||||
| 2012-12-31 | 301.75K shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |